Registry Study on Cystic Fibrosis in Chinese Children
ConditionCystic Fibrosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorBeijing Children's Hospital
About this trial
This study is a multicenter, prospective cohort study of patients diagnosed with cystic fibrosis, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.
Eligibility criteria
Qualifiers
Age 0~18 years old
Any organ system symptoms consistent with CF, such as chronic sinopulmonary disease, gastrointestinal and nutritional abnormalities, obstructive azoospermia or having siblings with CF
CFTR dysfunction indicated by elevated sweat chloride levels ≥60 mmol/L twice, or one sweat chloride levels ≥40 mmol/L plus presence of two pathogenic CFTR mutations on different alleles
Probable CF patients with sweat chloride levels among 40~59 mmol/L plus with presence of 0-1 pathogenic CFTR mutation
Disqualifiers
It is unable to provide complete medical records or the current condition can not accept the diagnosis process.
She or he does not agree to participate in the test.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Beijing Children's Hospital
Lead sponsor
Shengjing Hospital
Collaborator
Capital Institute of Pediatrics, China
Collaborator
Shanghai Children's Medical Center
Collaborator
Shenzhen Children's Hospital
Collaborator
The First Affiliated Hospital of Xiamen University
Collaborator
First Affiliated Hospital of Guangxi Medical University
Collaborator
Source ClinicalTrials.gov